Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta Variant.
- Abu-Raddad, Laith J
- Chemaitelly, Hiam
- Ayoub, Houssein H
- Yassine, Hadi M
- Benslimane, Fatiha M
- Al Khatib, Hebah A
- Tang, Patrick
- Hasan, Mohammad R
- Coyle, Peter
- AlMukdad, Sawsan
- Al Kanaani, Zaina
- Al Kuwari, Einas
- Jeremijenko, Andrew
- Kaleeckal, Anvar Hassan
- Latif, Ali Nizar
- Shaik, Riyazuddin Mohammad
- Abdul Rahim, Hanan F
- Nasrallah, Gheyath K
- Al Kuwari, Mohamed Ghaith
- Butt, Adeel A
- Al Romaihi, Hamad Eid
- Al-Thani, Mohamed H
- Al Khal, Abdullatif
- Bertollini, Roberto
DOIAbstract
Beta (B.1.351)-variant coronavirus disease 2019 (COVID-19) disease was investigated in Qatar. Compared with the Alpha (B.1.1.7) variant, odds (95% confidence interval) of progressing to severe disease, critical disease, and COVID-19-related death were 1.24-fold (1.11-1.39), 1.49-fold (1.13-1.97), and 1.57-fold (1.03-2.43) higher, respectively, for the Beta variant
Add to ORKG